HomeSearchNervno-Myshechnye Bolezni

Nervno-Myshechnye Bolezni

ABV-press Publishing House · Russian Federation · Est. 1988

ISSN2413-0443
SJR Q4Scopus / SJR
5
/ 100
High Risk
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
Scopus Q4+5
Total5
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗
SJR Scorei
0.142
H-Indexi
10
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIPi
0.308
Total Worksi
374
Total Citationsi
726
2yr Mean Citednessi
0.49
Open Impact Factor alternative

Aims & Scope

The journal is devoted to modern diagnostic tools and treatment of neuromuscular diseases. Recommended reading for neurologists, EDX and specialists in visualization in neurological and muscle diseases, geneticists, pedeiatricians, rehabilitation specialists and all interested. Reviews, outcomes of original studies, clinical cases, diagnostic guidelines, treatment options, reports on significant events in the field of neuromuscular diseases as well as historical aspects are presented.

⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Q4
SJR Rank
Bottom 25%

General Information

Country / RegionRussian Federation
Primary LanguageRussian, English
1st Year Published1988
Frequency4 issues per year
StatusActive (last: 2025)
Total Publications374
Publisher OrgABV-press
OA Since2014
Visit Journal Website

Submission Info

Peer Review
Review Time
Acceptance Rate
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

6/12 · 50%
Do you know the journal / publisher?
ABV-press Publishing House
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2413-0443
Indexed in a trusted database?
Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
Russian, English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
31
63
2019
40
96
2020
25
35
2021
29
52
2022
25
25
2023
37
30
2024
26
4
2025
6
0
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

NeurologyQ4
Neurology (clinical)Q4

Subject Classification

Scopus Categories

Neurology (clinical)Neurology

Research Topics (OpenAlex)

Neurogenetic and Muscular Disorders ResearchGenetic Neurodegenerative DiseasesHereditary Neurological DisordersMuscle Physiology and DisordersMyasthenia Gravis and ThymomaPeripheral Neuropathies and DisordersPeripheral Nerve DisordersGlycogen Storage Diseases and MyoclonusAmyotrophic Lateral Sclerosis ResearchTranscranial Magnetic Stimulation Studies

Frequently asked questions about Nervno-Myshechnye Bolezni

Is Nervno-Myshechnye Bolezni a predatory journal?

No major predatory indicators were found for Nervno-Myshechnye Bolezni. It is indexed in Scopus and has a PubScope Trust Score of 5/100. Always confirm fit and policies before submitting.

What is the impact factor of Nervno-Myshechnye Bolezni?

Nervno-Myshechnye Bolezni is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.142.

Is Nervno-Myshechnye Bolezni indexed in Scopus and Web of Science?

Nervno-Myshechnye Bolezni is indexed in Scopus.

What is the aims and scope of Nervno-Myshechnye Bolezni?

The journal is devoted to modern diagnostic tools and treatment of neuromuscular diseases. Recommended reading for neurologists, EDX and specialists in visualization in neurological and muscle diseases, geneticists, pedeiatricians, rehabilitation specialists and all interested. Reviews, outcomes of original studies, clinical cases, diagnostic guidelines, treatment options, reports on significant events in the field of neuromuscular diseases as well as historical aspects are presented.

Compare This JournalFind Similar← Back to Search

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref